News | November 08, 2023
Evonik launches GMP-quality plant-based squalene
PhytoSquene now available for clinical and commercial use
PhytoSquene now available for clinical and commercial use
Investment is additive to KKR’s existing health care growth strategy
Merck to pay Daiichi Sankyo a $4 billion upfront payment in addition to $1.5 billion in continuation payments over the next 24 months
Astria will assume full cost and responsibility for the global development and commercialization of the licensed therapeutic program for all indications
The RCSed's Court of Regents comprises a group of distinguished and accomplished individuals in their field
Honeywell Solstice Air is a hydrofluoroolefin (HFO) propellant in clinical development today for pMDIs
Chintan Shivir has provided a platform to hold discussions with higher officials and experts, which will help in evolving better practices of premier health institutions like AIIMS
Dignitaries and delegates commend India’s leadership in Global South during G20 India Presidency
Construction will begin this year with the new capacity anticipated by 2025
These announcements are in line with Croda Pharma’s strategy to “Empower Biologics Delivery” and follows news on investments, earlier this year, to expand Croda Pharma’s global manufacturing capabilities to enable the next generation vaccines and therapeutic drugs.
Subscribe To Our Newsletter & Stay Updated
